세계의 의료용 외골격 시장 규모 조사 및 예측 : 유형별, 이동성별, 구성요소별, 용도별, 지역별 분석(2023-2030년)

Global Medical Exoskeleton Market is valued at approximately USD 0.3 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 29.40% over the forecast period 2023-2030. Medical exoskeleton is a wearable robotic device designed to assist, enhance, or rehabilitate the physical abilities of its wearer. These devices are typically used in medical settings to aid individuals with mobility impairments, neurological disorders, or musculoskeletal injuries. Medical exoskeletons also help individuals with paralysis or mobility impairments to stand up, walk, and perform daily activities. They provide support to the user's limbs and augment their strength and coordination. Moreover, the increase in the prevalence of neurological disorders, rising the number of spinal cord injuries and brain injuries, the growing number of geriatric populations, and growing agreements and collaborations among companies and research organizations for the development of exoskeleton technology that anticipated to create the lucrative demand for the market during the forecast period 2023-2030.

Neurological disorders such as stroke, spinal cord injuries, multiple sclerosis, Parkinson's disease, and others can severely limit mobility and independence. Medical exoskeletons offer a solution by providing assistance and support to individuals with such conditions, enabling them to regain mobility and perform daily activities independently. According to the Parkinson's Foundation, more than 10 million people globally suffer from Parkinson's Disease (PD), and 60,000 Americans have been diagnosed with Parkinson's disease every year. Also, according to the World Health Organization, neurological disorders are responsible for 6.3% of the global disease burden. This has led to an increase in demand for innovative and effective treatments, which has driven the growth of the Medical Exoskeleton. Moreover, the rising number of product approvals by market players, and rising healthcare expenditure are anticipated to create a lucrative opportunity for the market. However, the regulatory challenges for securing approvals for medical exoskeletons, and high equipment cost stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Medical Exoskeleton Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rapid advancements in robotics, materials science, and artificial intelligence, supportive regulatory environment, and the presence of key market players. Whereas the Asia Pacific is expected to grow at the fastest growth rate during the forecast period, owing to factors such as the rising incidence of neurological disorders, increasing ageing population, and cohesive government initiatives and funding.

Major market players included in this report are:

• Ekso Bionics Holdings, Inc.
• ReWalk Robotics Ltd.
• Parker-Hannifin Corporation
• Cyberdyne, Inc.
• Bionik Laboratories Corp.
• Rex Bionics PLC
• B-TEMIA Incorporated
• Bioventus LLC
• Hocoma AG (part of DIH Technologies AG)
• Wearable Robotics SRL

Recent Developments in the Market:

• In December 2022, Ekso Bionics, a prominent figure in exoskeleton technology for medical and industrial applications, revealed its acquisition of the Human Motion and Control ("HMC") Business Unit from Parker Hannifin Corporation, a renowned global leader in motion and control technologies. Through this acquisition accompany expand its market presence globally.

Global Medical Exoskeleton Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Type, Mobility, Component, Application, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent to up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges that will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

• Powered exoskeleton
• Passive exoskeleton

By Mobility:

• Stationary
• Mobile

By Component:

• Hardware
• Software

By Application:

• Spinal Cord Injury
• Stroke
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

• 1.1.Market Snapshot
• 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1.Medical Exoskeleton Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2.Medical Exoskeleton Market, by Type, 2020-2030 (USD Billion)
  • 1.2.3.Medical Exoskeleton Market, by Mobility, 2020-2030 (USD Billion)
  • 1.2.4.Medical Exoskeleton Market, by Component, 2020-2030 (USD Billion)
  • 1.2.5.Medical Exoskeleton Market, by Application, 2020-2030 (USD Billion)
• 1.3.Key Trends
• 1.4.Estimation Methodology
• 1.5.Research Assumption

Chapter 2.Global Medical Exoskeleton Market Definition and Scope

• 2.1.Objective of the Study
• 2.2.Market Definition & Scope
  • 2.2.1.Industry Evolution
  • 2.2.2.Scope of the Study
• 2.3.Years Considered for the Study
• 2.4.Currency Conversion Rates

Chapter 3.Global Medical Exoskeleton Market Dynamics

• 3.1.Medical Exoskeleton Market Impact Analysis (2020-2030)
  • 3.1.1.Market Drivers
    • 3.1.1.1.Increase in the prevalence of neurological disorders
    • 3.1.1.2.Rising the number of spinal cord injuries and brain injuries
    • 3.1.1.3.Growing number of geriatric populations
  • 3.1.2.Market Challenges
    • 3.1.2.1.Regulatory challenges for securing approvals for medical exoskeletons
    • 3.1.2.2.High equipment cost
  • 3.1.3.Market Opportunities
    • 3.1.3.1.Increasing number of product approvals by market players
    • 3.1.3.2.Rising healthcare expenditure

Chapter 4.Global Medical Exoskeleton Market Industry Analysis

• 4.1.Porter's 5 Force Model
  • 4.1.1.Bargaining Power of Suppliers
  • 4.1.2.Bargaining Power of Buyers
  • 4.1.3.Threat of New Entrants
  • 4.1.4.Threat of Substitutes
  • 4.1.5.Competitive Rivalry
• 4.2.Porter's 5 Force Impact Analysis
• 4.3.PEST Analysis
  • 4.3.1.Political
  • 4.3.2.Economical
  • 4.3.3.Social
  • 4.3.4.Technological
  • 4.3.5.Environmental
  • 4.3.6.Legal
• 4.4.Top investment opportunity
• 4.5.Top winning strategies
• 4.6.COVID-19 Impact Analysis
• 4.7.Disruptive Trends
• 4.8.Industry Expert Perspective
• 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Medical Exoskeleton Market, by Type

• 5.1.Market Snapshot
• 5.2.Global Medical Exoskeleton Market by Type, Performance - Potential Analysis
• 5.3.Global Medical Exoskeleton Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
• 5.4.Medical Exoskeleton Market, Sub Segment Analysis
  • 5.4.1. Powered exoskeleton
  • 5.4.2.Passive exoskeleton

Chapter 6.Global Medical Exoskeleton Market, by Mobility

• 6.1.Market Snapshot
• 6.2.Global Medical Exoskeleton Market by Mobility, Performance - Potential Analysis
• 6.3.Global Medical Exoskeleton Market Estimates & Forecasts by Mobility 2020-2030 (USD Billion)
• 6.4.Medical Exoskeleton Market, Sub Segment Analysis
  • 6.4.1. Stationary
  • 6.4.2.Mobile

Chapter 7.Global Medical Exoskeleton Market, by Component

• 7.1.Market Snapshot
• 7.2.Global Medical Exoskeleton Market by Component, Performance - Potential Analysis
• 7.3.Global Medical Exoskeleton Market Estimates & Forecasts by Component 2020-2030 (USD Billion)
• 7.4.Medical Exoskeleton Market, Sub Segment Analysis
  • 7.4.1. Hardware
  • 7.4.2.Software

Chapter 8.Global Medical Exoskeleton Market, by Application

• 8.1.Market Snapshot
• 8.2.Global Medical Exoskeleton Market by Application, Performance - Potential Analysis
• 8.3.Global Medical Exoskeleton Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
• 8.4.Medical Exoskeleton Market, Sub Segment Analysis
  • 8.4.1. Spinal Cord Injury
  • 8.4.2.Stroke
  • 8.4.3.Others

Chapter 9.Global Medical Exoskeleton Market, Regional Analysis

• 9.1.Top Leading Countries
• 9.2.Top Emerging Countries
• 9.3.Medical Exoskeleton Market, Regional Market Snapshot
• 9.4.North America Medical Exoskeleton Market
  • 9.4.1.U.S. Medical Exoskeleton Market
    • 9.4.1.1.Type breakdown estimates & forecasts, 2020-2030
    • 9.4.1.2.Mobility breakdown estimates & forecasts, 2020-2030
    • 9.4.1.3.Component breakdown estimates & forecasts, 2020-2030
    • 9.4.1.4.Application breakdown estimates & forecasts, 2020-2030
  • 9.4.2.Canada Medical Exoskeleton Market
• 9.5.Europe Medical Exoskeleton Market Snapshot
  • 9.5.1.U.K. Medical Exoskeleton Market
  • 9.5.2.Germany Medical Exoskeleton Market
  • 9.5.3.France Medical Exoskeleton Market
  • 9.5.4.Spain Medical Exoskeleton Market
  • 9.5.5.Italy Medical Exoskeleton Market
  • 9.5.6.Rest of Europe Medical Exoskeleton Market
• 9.6.Asia-Pacific Medical Exoskeleton Market Snapshot
  • 9.6.1.China Medical Exoskeleton Market
  • 9.6.2.India Medical Exoskeleton Market
  • 9.6.3.Japan Medical Exoskeleton Market
  • 9.6.4.Australia Medical Exoskeleton Market
  • 9.6.5.South Korea Medical Exoskeleton Market
  • 9.6.6.Rest of Asia Pacific Medical Exoskeleton Market
• 9.7.Latin America Medical Exoskeleton Market Snapshot
  • 9.7.1.Brazil Medical Exoskeleton Market
  • 9.7.2.Mexico Medical Exoskeleton Market
• 9.8.Middle East & Africa Medical Exoskeleton Market
  • 9.8.1.Saudi Arabia Medical Exoskeleton Market
  • 9.8.2.South Africa Medical Exoskeleton Market
  • 9.8.3.Rest of Middle East & Africa Medical Exoskeleton Market

Chapter 10.Competitive Intelligence

• 10.1.Key Company SWOT Analysis
• 10.2.Top Market Strategies
• 10.3.Company Profiles
  • 10.3.1. Ekso Bionics Holdings, Inc.
    • 10.3.1.1.Key Information
    • 10.3.1.2.Overview
    • 10.3.1.3.Financial (Subject to Data Availability)
    • 10.3.1.4.Product Summary
    • 10.3.1.5.Recent Developments
  • 10.3.2.ReWalk Robotics Ltd.
  • 10.3.3.Parker-Hannifin Corporation
  • 10.3.4.Cyberdyne, Inc.
  • 10.3.5.Bionik Laboratories Corp.
  • 10.3.6.Rex Bionics PLC
  • 10.3.7.B-TEMIA Incorporated
  • 10.3.8.Bioventus LLC
  • 10.3.9.Hocoma AG (part of DIH Technologies AG)
  • 10.3.10.Wearable Robotics SRL

Chapter 11.Research Process

• 11.1.Research Process
  • 11.1.1.Data Mining
  • 11.1.2.Analysis
  • 11.1.3.Market Estimation
  • 11.1.4.Validation
  • 11.1.5.Publishing
• 11.2.Research Attributes
• 11.3.Research Assumption